Jump to content

Deadly Marburg virus spreads in Rwanda, with no vaccine or treatment – National


Recommended Posts

  • Author


Rwanda says eight people have died so far from the Ebola-like and highly contagious Marburg virus, just days after the country declared an outbreak of the deadly hemorrhagic fever that has no authorized vaccine or treatment.

70c8fc80

Like Ebola, the Marburg virus originates in fruit bats and spreads between people through close contact with the bodily fluids of infected individuals or with surfaces, such as contaminated bed sheets. Without treatment, Marburg can be fatal in up to 88 per cent of people who fall ill with the disease.

Rwanda, a landlocked country in central Africa, declared an outbreak on Friday and a day later the first six deaths were reported.

So far 26 cases have been confirmed, and eight of the sickened people have died, Health Minister Sabin Nsanzimana said on Sunday night.

The public has been urged to avoid physical contact to help curb the spread. Some 300 people who came into contact with those confirmed to have the virus have also been identified, and an unspecified number of them have been put in isolation facilities.

Story continues below advertisement

Most of the affected are healthcare workers across six out of 30 districts in the country.


Click to play video: 'WHO says 4 high-risk contacts identified after case of Marburg virus reported in Guinea'


WHO says 4 high-risk contacts identified after case of Marburg virus reported in Guinea


“Marburg is a rare disease,” Nsanzimana told journalists. “We are intensifying contact tracing and testing to help stop the spread.”

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

The minister said the source of the disease has not been determined yet. A person infected with the virus can take between three days and three weeks to show symptoms, he added.

Symptoms include fever, muscle pains, diarrhea, vomiting and, in some cases, death through extreme blood loss.

The World Health Organization was scaling up its support and will work with Rwandan authorities to help stop the spread, WHO’s Director-General Tedros Adhanom Ghebreyesus said on Saturday on the social media platform X.

The U.S Embassy in Rwanda’s capital of Kigali has urged its staff to work remotely and avoid visiting offices.

Story continues below advertisement

Marburg outbreaks and individual cases have in the past been recorded in Tanzania, Equatorial Guinea, Angola, Congo, Kenya, South Africa, Uganda and Ghana, according to the WHO.

The rare virus was first identified in 1967 after it caused simultaneous outbreaks of disease in laboratories in Marburg, Germany, and Belgrade, Serbia. Seven people died who were exposed to the virus while conducting research on monkeys.

Separately, Rwanda has so far reported six cases of mpox, a disease caused by a virus related to smallpox but that typically causes milder symptoms. Mpox, previously known as monkeypox because it was first seen in research monkeys, has also affected several other African countries in what the WHO has called a global health emergency.

Rwanda launched an mpox vaccination campaign earlier this month, and more vaccines are expected to arrive in the country. Neighboring Congo has so far reported most of the cases of mpox, the epicenter of the emergency.


&copy 2024 The Canadian Press




Source link

#Deadly #Marburg #virus #spreads #Rwanda #vaccine #treatment #National

The post Deadly Marburg virus spreads in Rwanda, with no vaccine or treatment – National appeared first on 247 News Center.

Source Link

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

Cookie Consent & Terms We use cookies to enhance your experience on our site. By continuing to browse our website, you agree to our use of cookies as outlined in our We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.. Please review our Terms of Use, Privacy Policy, and Guidelines for more information.